Maleimide prodrug having biological adhesion effect and application of maleimide prodrug in oral medicine transmission

A maleimide-type, maleimidocaproyloxymethyl technology, applied in the new application field of prodrug preparations, can solve poor patient compliance, inconvenient administration, heart, liver and kidney toxicity side effects and other issues to achieve the effect of increasing compliance and reducing risks

Active Publication Date: 2018-06-15
SHENYANG PHARMA UNIVERSITY
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, most anti-tumor drugs are mainly applied to patients by injection. Due to the defects of the injection route itsel...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Maleimide prodrug having biological adhesion effect and application of maleimide prodrug in oral medicine transmission
  • Maleimide prodrug having biological adhesion effect and application of maleimide prodrug in oral medicine transmission
  • Maleimide prodrug having biological adhesion effect and application of maleimide prodrug in oral medicine transmission

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Preparation of 1-(6-maleimidocaproyloxymethyl)-5-fluorouracil

[0039] (a) Dissolve 9.806g (100mmol) of maleic anhydride and 13.118g (100mmol) of 6-aminocaproic acid in 100mL of glacial acetic acid, react at 120°C for 3-4h, remove organic reagents by rotary evaporation, use toluene with water, acetic acid After ethyl ester extraction, the organic layers were combined, anhydrous sodium sulfate was added and stirred to remove water, and column chromatography gave white intermediate (I).

[0040] (b) Dissolve 8.45 g (65 mmol) of 5-fluorouracil in a certain volume of 37% formaldehyde solution, react at 50°C for about 4 hours, and concentrate the reaction solution under reduced pressure to obtain a transparent liquid intermediate (II).

[0041] (c) 11.4g (54mmol) of 6-maleimidocaproic acid, 26.7g (70mmol) of HATU and 14.85mL (135mmol) of N-methylmorpholine were dissolved in 150mL of anhydrous acetonitrile, and the activation. Dissolve (Ⅲ) in acetonitrile and slowly transfe...

Embodiment 2

[0044] Determination of Equilibrium Solubility and Oil-Water Partition Coefficient

[0045] Add excess 1-(6-maleimidocaproyloxymethyl)-5-fluorouracil to water, pH 1.2 PBS and PEG400 aqueous solutions with different contents, vortex for 5min, and then place in a constant temperature shaker at 37°C Shake in the box for 72h to make the dissolution reach equilibrium. The suspension was centrifuged at 12,000 r for 10 min, and the supernatant was filtered. After appropriate dilution, the drug concentration was measured by high performance liquid chromatography, and its equilibrium solubility in different media was calculated. The results are shown in Table 1.

[0046] Table 1

[0047]

[0048] Weigh respectively 5-fluorouracil and 1-(6-maleimidocaproyloxymethyl)-5-fluorouracil in appropriate amount in water-saturated n-octanol (n-octanol-saturated water), respectively Mix it with n-octanol-saturated water (water-saturated n-octanol) in equal volume, shake in a shaker at 37°C fo...

Embodiment 3

[0053] Study on the Stability of 1-(6-maleimidocaproyloxymethyl)-5-fluorouracil

[0054] Weigh an appropriate amount of 1-(6-maleimidocaproyloxymethyl)-5-fluorouracil, add appropriate amount of water to dissolve to prepare a stock solution with a concentration of about 200 μg / ml. Take an appropriate amount of the stock solution, and dilute it with phosphate buffer solution of pH 1.2, 4.5, 6.8 and 7.4 respectively, mix thoroughly, and perform triplicate. Put it in a constant temperature oscillator at 37°C by the classical constant temperature method, take samples at 0, 0.25, 0.5, 1, 2, 4, 8 and 12 hours, pass through a 0.45 μm filter membrane, and inject 10 μL into high performance liquid chromatography.

[0055] Artificial gastric fluid (SGF) and intestinal fluid (SIF) were prepared according to the Chinese Pharmacopoeia 2015 edition. Take an appropriate amount of stock solution, dilute and mix with artificial gastric juice and intestinal juice respectively, and make triplica...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of medicine, and relates to a maleimide prodrug taking mucoprotein as a target point in promotion of biological adhesion and an application of the maleimide prodrug in increasing of oral drug absorption. The maleimide prodrug has a structural formula shown in a formula (I): wherein n is 2-8, and X is O, N. The prodrug has the advantages of high compounddrug loading, good stability, and safety, and can be used for oral administration. The carried maleimide group can be specifically combined with mucoprotein in a mucous layer in gastrointestinal tract, a mucoprotein-prodrug compound is formed, detention time of the prodrug in the gastrointestinal tract is prolonged, concentration gradient of an adsorption-absorption part is increased, passive diffusion is promoted, and oral absorption is promoted. The invention provides the novel maleimide prodrug having the biological adhesion effect for oral absorption of the drug.

Description

technical field [0001] The invention belongs to the technical field of new applications of prodrug preparations, and relates to a class of maleimide prodrugs with bioadhesive effect and their application in oral drug delivery. Background technique [0002] Malignant tumors seriously threaten human life and health, and its morbidity and mortality are increasing year by year. At present, most anti-tumor drugs are mainly applied to patients by injection. Due to the defects of the injection route itself, such as pain, inconvenient administration and poor patient compliance, it will cause serious heart, liver and kidney side effects. . Oral administration is a convenient and safe way of administration, which has good patient compliance and avoids the toxic and side effects caused by injection. Oral absorption of drugs is affected by many factors, such as drug solubility, permeability, and first-pass effect in the liver. Therefore, how to improve the bioavailability of antitumor...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D403/12A61P35/00
CPCC07D403/12
Inventor 孙进何仲贵刘岩
Owner SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap